{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:10:00Z","timestamp":1792455000336,"version":"4.5.0"},"reference-count":27,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,2,13]]},"DOI":"10.3233\/jhd-190001","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:31:13Z","timestamp":1550226673000},"page":"115-125","source":"Crossref","is-referenced-by-count":30,"title":["Huntington\u2019s Disease Clinical Trials Corner: January 2019"],"prefix":"10.1177","volume":"8","author":[{"given":"Filipe B.","family":"Rodrigues","sequence":"first","affiliation":[{"name":"UCL Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK"},{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, PT"},{"name":"Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, PT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Biobehavioral Sciences, Teachers College, Columbia University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[{"name":"UCL Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"3","key":"10.3233\/JHD-190001_ref3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JHD-170262","article-title":"Clinical Trials Corner: September 2017","volume":"6","author":"Rodrigues","year":"2017","journal-title":"Journal of Huntingtons Disease"},{"key":"10.3233\/JHD-190001_ref4","unstructured":"Reilmann R , McGarry A , Grachev ID , Savola J-M , Borowsky B , Eyal E , et al. Safety and efficacy of pridopidine in patients with Huntington\u2019s disease (PRIDE-HD): A phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. Lancet Neurology. 2018."},{"issue":"12","key":"10.3233\/JHD-190001_ref5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington\u2019s disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"de Yebenes","year":"2011","journal-title":"Lancet Neurology"},{"issue":"10","key":"10.3233\/JHD-190001_ref6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.25362","article-title":"A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington\u2019s disease","volume":"28","author":"Huntington Study Group HART Investigators","year":"2013","journal-title":"Movement Disorders"},{"issue":"5","key":"10.3233\/JHD-190001_ref7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNF.0b013e3181ebb285","article-title":"Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington\u2019s disease","volume":"33","author":"Lundin","year":"2010","journal-title":"Clinical Neuropharmacol"},{"issue":"10","key":"10.3233\/JHD-190001_ref8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurology"},{"issue":"24","key":"10.3233\/JHD-190001_ref10","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","article-title":"Motor, cognitive, and functional declines contribute to a single progressive factor in early HD","volume":"89","author":"Schobel","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JHD-190001_ref15","first-page":"90","article-title":"Effects of IONIS-HTTRx in patients with early huntington\u2019s disease, results of the first HTT-lowering drug trial","author":"Tabrizi","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JHD-190001_ref16","first-page":"1182","article-title":"Design of a prospective, longitudinal, natural history study in huntington disease","volume":"15","author":"Hooper","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.3233\/JHD-190001_ref17","first-page":"1186","article-title":"Enrichment strategy in early-to-moderate manifest huntington disease based on CAG\/Age product (CAP) >400 threshold","volume":"15","author":"Long","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JHD-190001_ref18","unstructured":"National Institute for Health and Care Excellence. Parkinson\u2019s disease in adults (NG71) 2017 [Available from: nice.org.uk\/guidance\/ng71."},{"key":"10.3233\/JHD-190001_ref19","unstructured":"National Institute for Health and Care Excellence. Multiple sclerosis in adults: Management (CG186) 2014 [Available from: nice.org.uk\/guidance\/cg186."},{"key":"10.3233\/JHD-190001_ref20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.expneurol.2013.07.014","article-title":"Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6\/1 Huntington\u2019s disease mouse model","volume":"248","author":"Harrison","year":"2013","journal-title":"Experimental Neurology"},{"key":"10.3233\/JHD-190001_ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2017.05.004","article-title":"Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG140 knock-in mouse model of Huntington\u2019s disease","volume":"105","author":"Stefanko","year":"2017","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"10.3233\/JHD-190001_ref22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/NPT.0000000000000016","article-title":"A randomized feasibility study of a 12-week community-based exercise program for people with Huntington\u2019s disease","volume":"37","author":"Busse","year":"2013","journal-title":"Journal of Neurologic Physical Therapy"},{"issue":"11","key":"10.3233\/JHD-190001_ref23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2522\/ptj.20140123","article-title":"Task-specific training in Huntington disease: A randomized controlled feasibility trial","volume":"94","author":"Quinn","year":"2014","journal-title":"Physical Therapy"},{"key":"10.3233\/JHD-190001_ref24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2016.06.023","article-title":"A randomized, controlled trial of a multi-modal exercise intervention in Huntington\u2019s disease","volume":"31","author":"Quinn","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.3233\/JHD-190001_ref25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ptj\/pzx031","article-title":"Physical activity self-management and coaching compared to social interaction in huntington disease: Results from the ENGAGE-HD randomized, controlled pilot feasibility trial","volume":"97","author":"Busse","year":"2017","journal-title":"Physical Therapy"},{"issue":"9","key":"10.3233\/JHD-190001_ref26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/ene.12053","article-title":"The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington\u2019s disease: A pilot study","volume":"20","author":"Thompson","year":"2013","journal-title":"European Journal of Neurology"},{"key":"10.3233\/JHD-190001_ref27","first-page":"5","article-title":"Effects of a one year intensive multidisciplinary rehabilitation program for patients with huntington\u2019s disease: A prospective intervention study","author":"Piira","year":"2013","journal-title":"PLoS Currents"},{"key":"10.3233\/JHD-190001_ref28","first-page":"6","article-title":"Effects of a two-year intensive multidisciplinary rehabilitation program for patients with huntington\u2019s sisease: A prospective intervention study","author":"Piira","year":"2014","journal-title":"PLoS Currents"},{"issue":"1","key":"10.3233\/JHD-190001_ref29","first-page":"47","article-title":"Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington\u2019s disease","volume":"30","author":"Ciancarelli","year":"2015","journal-title":"Functional Neurology"},{"issue":"2","key":"10.3233\/JHD-190001_ref30","doi-asserted-by":"crossref","first-page":"e00312","DOI":"10.1002\/brb3.312","article-title":"The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington\u2019s disease: An exploratory study","volume":"5","author":"Cruickshank","year":"2015","journal-title":"Brain and Behavior"},{"issue":"3","key":"10.3233\/JHD-190001_ref31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-170260","article-title":"Physical therapy and exercise interventions in huntington\u2019s disease: A mixed methods systematic review","volume":"6","author":"Fritz","year":"2017","journal-title":"Journal of Huntingtons Disease"},{"issue":"7","key":"10.3233\/JHD-190001_ref32","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.11124\/JBISRIR-2016-003274","article-title":"Physical therapy and exercise interventions in Huntington\u2019s disease: A mixed methods systematic review protocol","volume":"15","author":"Quinn","year":"2017","journal-title":"JBI Database of Systematic Reviews and Implementation Reports"},{"issue":"1","key":"10.3233\/JHD-190001_ref33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-189001","article-title":"Huntington\u2019s Disease Clinical Trials Corner: February 2018","volume":"7","author":"Rodrigues","year":"2018","journal-title":"Journal of Huntingtons Disease"},{"issue":"3","key":"10.3233\/JHD-190001_ref34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JHD-189003","article-title":"Huntington\u2019s Disease Clinical Trials Corner: August 2018","volume":"7","author":"Rodrigues","year":"2018","journal-title":"Journal of Huntingtons Disease"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-190001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:45Z","timestamp":1777452645000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-190001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":27,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-190001","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]}}}